Comparative Effectiveness of Dupilumab and Omalizumab in Improving Exacerbations in Individuals With Allergic Asthma

被引：0
|
作者：
Nopsopon, T. [1 ]
Zhou, G. [2 ]
Hu, R. [2 ]
Keet, C. [3 ]
Akenroye, A. [1 ]
机构：
[1] Brigham & Womens Hosp, Allergy & Clin Immunol, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Med, 75 Francis St, Boston, MA 02115 USA
[3] Univ N Carolina, Pediat Allergy & Immunol, Chapel Hill, NC 27515 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6650
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Omalizumab for Severe Asthma: Beyond Allergic Asthma
    Loureiro, C. C.
    Amaral, L.
    Ferreira, J. A.
    Lima, R.
    Pardal, C.
    Fernandes, I.
    Semedo, L.
    Arrobas, A.
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [32] Asthma exacerbations after discontinuation of omalizumab treatment
    Budny, Wojciech
    Skiepko, Roman
    Lukaszyk, Mateusz
    Klimek, Maciej
    Ki, Ziemowit Zietkows
    Bodzenta-Lukaszyk, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2015, 20 (04): : 253 - 256
  • [33] Asthma exacerbations after omalizumab treatment discontinuation
    Budny, W.
    Skiepko, R.
    Lukaszyk, M.
    Zietkowski, Z.
    Bodzenta-Lukaszyk, A.
    ALLERGY, 2015, 70 : 554 - 554
  • [34] EFFECTIVENESS OF OMALIZUMAB ON ASTHMA CONTROL AND LUNG FUNCTION IN SEVERE ALLERGIC ASTHMA PATIENTS IN THE CZECH REPUBLIC
    Sedlak, V.
    THORAX, 2011, 66 : A111 - A111
  • [35] COSTS COMPARISON BETWEEN DUPILUMAB AND OMALIZUMAB IN THE TREATMENT OF SEVERE ALLERGIC ASTHMA IN THE BRAZILIAN PRIVATE HEALTHCARE PERSPECTIVE
    Barbosa, A.
    Magro, F. J. B.
    Taminato, A.
    Federico, P.
    Prioli, R. N. T.
    Goldflus, S.
    Migliavaca, C. B.
    Falavigna, M.
    VALUE IN HEALTH, 2022, 25 (12) : S164 - S164
  • [36] Omalizumab therapy reduces asthma exacerbations and is rated as effective by physicians in children with severe allergic (IgE-mediated) asthma
    Kulus, M.
    Hebert, J.
    Garcia, E.
    Taylor, A. F.
    Vidaurre, C. F.
    Blogg, M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (12): : 1952 - 1952
  • [37] Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
    Nissen, Francis
    Humbert, Marc
    Gibson, Peter
    Kostikas, Konstantinos
    Jaumont, Xavier
    Tassinari, Paolo
    Pfister, Pascal
    Bousquet, Jean
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [38] Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
    Carlos A. Torres-Duque
    Jaime Ocampo-Gómez
    Mauricio Morales Castillo
    Diana Cano-Rosales
    Ángela Giraldo-Montoya
    Freddy Rodríguez
    Isabel Palacios-Ortega
    Mauricio Durán-Silva
    Humberto Reynales
    Elizabeth García
    BMC Pulmonary Medicine, 22
  • [39] Effectiveness of 52 weeks of omalizumab therapy in patients with severe persistent allergic asthma
    Skiepko, R.
    Zietkowski, Z.
    Tomasiak, M.
    Lenczewska, D.
    Bodzenta-Lukaszyk, A.
    Skiepko, R.
    Skiepko, R.
    ALLERGY, 2010, 65 : 552 - 553
  • [40] Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
    Galanakis, Petros
    Gaga, Mina
    Psarros, Fotios
    Zervas, Eleftherios
    Mitsiki, Eirini
    Siafakas, Nikolaos
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
12345